CAS: 1802086-25-4
Gastric Inhibitory Polypeptide (3-42) (human)
CAS:1802086-25-4
Gastric inhibitory polypeptide (3-42) represents the major physiological degradation product of gastric inhibitory polypeptide (GIP). …
Fórmula:
C214H324N58O63S
Pureza:
96.1%
Forma y color:
White Powder
Peso molecular:
4749.35
Ref: 01-4034653
| 1mg | 617,00 € | ||
| 0.5mg | 350,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025
GIP (3-42), human
CAS:1802086-25-4
Human GIP (3-42) is a peptide antagonist of GIP receptors, affecting insulin regulation and diabetes …
Fórmula:
C214H324N58O63S
Pureza:
98%
Forma y color:
Liquid
Peso molecular:
4749.35
Ref: TM-T37589
| 1mg | 185,00 € | ||
| 5mg | 459,00 € | ||
| 10mg | 656,00 € | ||
| 25mg | 1.027,00 € | ||
| 50mg | 1.403,00 € | ||
| 100mg | 1.865,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
GIP (3 - 42), human
CAS:1802086-25-4
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool
Fórmula:
C214H324N58O63S
Peso molecular:
4,749.38 g/mol
Ref: 3D-PP50414
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 31 de Enero de 2025
Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt
CAS:1802086-25-4
Please enquire for more information about Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt including the …
Fórmula:
C214H324N58O63S
Pureza:
Min. 95%
Peso molecular:
4,749.28 g/mol
Ref: 3D-FG109902
| 1mg | 1.025,00 € | ||
| 2mg | 1.671,00 € | ||
| 100µg | 338,00 € | ||
| 250µg | 400,00 € | ||
| 500µg | 615,00 € |
Entrega estimada en Estados Unidos, el Lunes 17 de Marzo de 2025
